Paste your practice website. Get a live compliance score in seconds.
Built on FDA and FTC enforcement patterns in regenerative medicine marketing.
✓ See your score instantly -- no email, no signup
This just scans your site's public pages. No personal info is submitted until you choose to enter it below.
Your license is what's actually on the line here!!
Regulators don't send a warning before the warning letter.
Every week your site stays unreviewed is another week of exposure.
Enter your info below. Your full report, including exactly which pages and claims are driving your score, goes to your email.
This report is yours whether you work with us or not. If it leads to us working together, good. If not, you still know exactly where your risk is.
Your report is emailed to you and kept on file so we can follow up if you want help. It isn't shared with anyone else, including regulators.
What happens next: your report by email, one call from us to walk through it. No sequence, no spam. Opt out any time.
Your site is scanned against six categories FDA and FTC have cited in real enforcement actions against regenerative medicine practices, plus federal disclosure requirements for regenerative treatment marketing.
FDA and FTC enforcement against stem cell and exosome marketing has increased steadily. A warning letter does not start with a lawsuit. It starts with marketing language someone flagged. Most practices never see the letter coming, because the language that triggers it usually reads as ordinary marketing copy, not as a claim.
Built by Karlista Maroney, founder of DIGICO and physician marketing strategist who's worked with 30+ regenerative medicine physicians and spoken to 600+ doctors on patient trust and communication.